No results for ‘’
Amkay Products Ltd
NSE: BSE: 544169
₹51.75
(11.97%)
Wed, 09 Sept 2026, 11:09 pm
Market Cap (in Cr)50.89
PE Ratio19.36
Dividend0
Health Technology
Medical Specialties
24.5KAmkay Products Income Statement
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total revenue | 406.84M | 364.69M | 278.64M | 310.69M | 383.90M |
| Gross profit | 86.87M | 43.00M | 42.72M | 53.80M | 78.49M |
| Operating expenses (excl. COGS) | -43.27M | -21.56M | -20.34M | -23.42M | -45.30M |
| Selling/general/admin expenses, total | -41.82M | -21.09M | -20.34M | -23.42M | -45.01M |
| Research & development | — | — | — | — | — |
| Selling/general/admin expenses, other | -41.82M | -21.09M | -20.34M | -23.42M | -45.01M |
| Other operating expenses, total | -1.45M | -472.00K | 0 | 0 | -289.00K |
| Operating income | 43.60M | 21.44M | 22.38M | 30.38M | 33.19M |
| Non-operating income, total | -1.84M | -1.09M | -53.00K | 4.63M | 9.78M |
| Interest expense, net of interest capitalized | -2.02M | -3.98M | -4.70M | -5.22M | -3.17M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 178.00K | 2.90M | 4.65M | 9.85M | 12.95M |
| Non-operating interest income | 799.00K | 1.48M | 1.06M | 318.00K | 1.43M |
| Miscellaneous non-operating expense | -621.00K | 1.42M | 3.59M | 9.54M | 11.52M |
| Unusual income/expense | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 41.76M | 20.35M | 22.32M | 35.01M | 42.98M |
| Taxes | -10.49M | -5.68M | -6.83M | -8.71M | -9.59M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 31.27M | 14.67M | 15.49M | 26.30M | 33.38M |
| Net income | 31.27M | 14.67M | 15.49M | 26.30M | 33.38M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 31.27M | 14.67M | 15.49M | 26.30M | 33.38M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - |
| EBITDA | 46.44M | 26.81M | 29.29M | 35.94M | 41.49M |
| EBIT | 43.60M | 21.44M | 22.38M | 30.38M | 33.19M |
| Total operating expenses | -363.24M | -343.25M | -256.27M | -280.31M | -350.71M |
| Prepaid expenses | 138.00K | 58.00K | 163.00K | 272.00K | 476.00K |
| Deferred income, current | 4.27M | 1.85M | 1.13M | 1.03M | 1.58M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | — |
| Deferred income, non-current | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 |